- Clinical management of uveal melanoma: a comprehensive review with a treatment algorithm
-
Sayan M, Mamidanna S, Oncel D, Jan I, Vergalasova I, Weiner J, Ohri N, Acikalin B, Chundury A
- KMID: 2506931
- Radiat Oncol J.
- 2020 Sep;38(3):162-169.
- doi: 10.3857/roj.2020.00318
Uveal melanoma (UM), the most frequently occurring non-cutaneous melanoma and most common primary intraocular malignancy in adults, arises from the melanocytes of the choroid in approximately 95% of cases. Prompt... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases
-
Sayan M, Zoto Mustafayev T, Sahin B, Kefelioglu ESS, Wang SJ, Kurup V, Balmuk A, Gungor G, Ohri N, Weiner J, Ozyar E, Atalar B
- KMID: 2468735
- Radiat Oncol J.
- 2019 Dec;37(4):265-270.
- doi: 10.3857/roj.2019.00409
PURPOSE: Renal cell carcinoma (RCC) and melanoma have been considered ‘radioresistant’ due to the fact that they do not respond to conventionally fractionated radiation therapy. Stereotactic radiosurgery (SRS) provides high-dose... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of symptomatic radiation necrosis after stereotactic radiosurgery and clinical factors for treatment response
-
Sayan M, Mustafayev TZ, Balmuk A, Mamidanna S, Kefelioglu ESS, Gungor G, Chundury A, Ohri N, Karaarslan E, Ozyar E, Atalar B
- KMID: 2506933
- Radiat Oncol J.
- 2020 Sep;38(3):176-180.
- doi: 10.3857/roj.2020.00171
Purpose: Approximately 10% of patients who received brain stereotactic radiosurgery (SRS) develop symptomatic radiation necrosis (RN). We sought to determine the effectiveness of treatment options for symptomatic RN, based on... -
- CITED
-
- Close
- SHARE
-
- Close
